nasdaq
Netflix is set to report its second-quarter earnings after the bell on Thursday, and all eyes are on the streaming giant’s progress with its advertising-supported business model. Launched in late 2022, the ad-supported tier is seen as a critical component of Netflix’s strategy to boost revenue and profitability. Wall Street analysts are keen to hear updates on this initiative, alongside the company’s overall performance metrics. Nexflix Q2: What’s expected?For Q2 2023, Wall Street analysts are forecasting earnings per share (EPS) of $4.74, according to data from LSEG. Revenue is expected to re...
Invezz
GitLab Inc. (NASDAQ: GTLB), a prominent cloud-based software development tools provider, is garnering a lot of attention today with a significant 9% jump in its stock price following reports of a potential sale. This news has catalyzed interest in a company that’s already a giant in the DevSecOps arena, boasting over 30 million registered users and serving more than half of the Fortune 100 companies. GitLab’s potential saleEarlier today, Reuters broke the news that GitLab, backed by Alphabet’s Google, is exploring strategic options, including a sale. This move comes at a time when GitLab has b...
Invezz
In a move signaling its commitment to enhancing its cybersecurity offerings, Alphabet Inc. (NASDAQ: GOOG) is reportedly nearing its largest acquisition ever. According to a Wall Street Journal report from July 14, 2024, Alphabet is in advanced discussions to acquire the cybersecurity startup Wiz for approximately $23 billion. This potential acquisition not only marks a significant expansion for Google’s suite of services but also reflects the company’s strategic pivot towards strengthening its cloud computing offerings, an area where it currently trails behind industry leaders Amazon Web Servi...
Invezz
Sarepta Therapeutics (NASDAQ: SRPT), a pharmaceutical company that describes itself as specializing in “precision genetic medicine for rare diseases”, saw its stock price shoot up by 36% in after-hours trading last night. But why? Ground-breaking medical breakthroughToward the end of the trading day yesterday, Sarepta announced that it had obtained approval from the U.S. Food and Drug Administration (FDA) for a treatment targeting a rare genetic disease called Duchenne muscular dystrophy (DMD). Sarepta’s DMD treatment, named ELEVIDYS (delandistrogene moxeparvovec-rokl), was given full FDA appr...
Invezz
Nasdaq-listed software firm MicroStrategy (MSTR) has expanded its substantial bitcoin (BTC) holdings, acquiring an additional 11,931 BTC for $786 million. This latest acquisition further cements MicroStrategy’s position as the largest corporate holder of bitcoin. MicroStrategy’s bitcoin accumulation strategy Led by Executive Chairman Michael Saylor, MicroStrategy began its aggressive bitcoin accumulation in 2020. As of the end of April, the company held 214,400 bitcoins. With the recent purchase, the total now stands at 226,331 bitcoins, valued at just under $15 billion, given bitcoin’s curren...
Invezz
Nasdaq Stockholm, Nasdaq Inc’s stock exchange in Sweden, has been fined 100 million Swedish kronor ($9.6 million) by the country’s financial watchdog, the Financial Supervisory Authority (Finansinspektionen), over deficiencies in monitoring insider trading violations. The regulatory body found flaws in how Nasdaq Stockholm conducted its trade monitoring during significant company events in 2021 and 2022. Deficiencies in trade monitoringThe investigation by the Financial Supervisory Authority revealed that Nasdaq Stockholm had shortcomings in its processes to prevent, identify, and report insid...
Invezz
ValueWalk
ValueWalk
ValueWalk
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら